Parkside Financial Bank & Trust Sarepta Therapeutics, Inc. Transaction History

Parkside Financial Bank & Trust

  • $742 Million
  • Q4 2024

A detailed history of Parkside Financial Bank & Trust transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 19 shares of SRPT stock, worth $1,957. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19
Previous 13 46.15%
Holding current value
$1,957
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025
BUY
$104.54 - $137.94 $627 - $827
6 Added 46.15%
19 $2,000
Q2 2024

Aug 05, 2024
SELL
$113.33 - $163.85 $3,626 - $5,243
-32 Reduced 71.11%
13 $2,000
Q1 2024

May 01, 2024
BUY
$93.7 - $141.53 $2,529 - $3,821
27 Added 150.0%
45 $5,000
Q4 2023

Feb 01, 2024
BUY
$67.31 - $124.76 $673 - $1,247
10 Added 125.0%
18 $1,000
Q3 2023

Nov 13, 2023
BUY
$102.5 - $123.59 $102 - $123
1 Added 14.29%
8 $0
Q4 2022

Feb 13, 2023
BUY
$100.86 - $132.13 $706 - $924
7 New
7 $0
Q2 2022

Jul 13, 2022
SELL
$62.69 - $88.44 $1,316 - $1,857
-21 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$63.15 - $90.42 $3,410 - $4,882
-54 Reduced 72.0%
21 $2,000
Q4 2021

Feb 14, 2022
SELL
$77.28 - $99.42 $309 - $397
-4 Reduced 5.06%
75 $7,000
Q3 2021

Oct 29, 2021
BUY
$65.97 - $92.48 $3,364 - $4,716
51 Added 182.14%
79 $7,000
Q2 2021

Aug 06, 2021
BUY
$69.38 - $86.75 $1,387 - $1,735
20 Added 250.0%
28 $2,000
Q1 2021

May 10, 2021
BUY
$72.25 - $168.95 $361 - $844
5 Added 166.67%
8 $1,000
Q4 2020

Feb 09, 2021
SELL
$125.56 - $178.74 $2,260 - $3,217
-18 Reduced 85.71%
3 $1,000
Q3 2020

Nov 06, 2020
BUY
$127.12 - $172.34 $762 - $1,034
6 Added 40.0%
21 $3,000
Q2 2020

Aug 10, 2020
SELL
$93.0 - $171.7 $2,046 - $3,777
-22 Reduced 59.46%
15 $2,000
Q1 2020

May 05, 2020
SELL
$82.38 - $131.64 $1,565 - $2,501
-19 Reduced 33.93%
37 $4,000
Q3 2019

Nov 05, 2019
SELL
$72.81 - $156.91 $5,533 - $11,925
-76 Reduced 57.58%
56 $4,000
Q1 2019

May 01, 2019
BUY
$106.67 - $151.68 $6,400 - $9,100
60 Added 83.33%
132 $16,000
Q4 2018

Jan 31, 2019
SELL
$97.32 - $148.76 $389 - $595
-4 Reduced 5.26%
72 $8,000
Q4 2017

Feb 05, 2018
SELL
$47.64 - $56.75 $428 - $510
-9 Reduced 10.59%
76 $4,000
Q3 2017

Oct 27, 2017
BUY
$35.73 - $47.15 $3,037 - $4,007
85
85 $4,000

Others Institutions Holding SRPT

# of Institutions
536
Shares Held
87.4M
Call Options Held
1.55M
Put Options Held
1.35M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.02B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email